Global Parkinson's Disease Market Research - Frontier Pharma - JSB Market Research

About This Presentation

Global Parkinson's Disease Market Research - Frontier Pharma - JSB Market Research


The report examines and analyzes innovation in global parkinsons disease market in the context of the overall pipeline and current market landscape. It provides a brief introduction to parkinson's disease pathophysiology including symptoms and an overview of pharmacotherapy. Browse full report @ – PowerPoint PPT presentation

Number of Views:40


Transcript and Presenter's Notes

Title: Global Parkinson's Disease Market Research - Frontier Pharma - JSB Market Research

Global Parkinson's Disease Market Research -
Frontier Pharma
To buy this Report Visit http//www.jsbmarketresea
Buy 2 Reports Get 1 Free Click Here For
Special Discount Offer On Infiniti Research
Limited http//
r/infiniti-research-limited For more inquiries,
contact at 91 - 998 729 5242 /contact_at_jsbmarket
To buy this Report Visit http//www.jsbmarketresea
SummaryLarge Degree of Innovation
in Parkinsons Disease Pipeline
  • The Parkinsons disease (PD) pipeline currently
    has 302 products in active development across all
    stages, but a stark contrast between the
    mechanisms of action employed in the current
    market and the pipeline is evident. Where the
    market relies on symptomatic treatments that
    target neuromodulatory receptors, the pipeline
    shows a diverse range of neuroprotective
    therapies targeting dysfunctional disease
    processes. This diversity is partially due to the
    presence of 90 first-in-class products, which
    accounts for 37 of the overall pipeline
    therapies that disclosed their target. In an
    industry, market and development landscape that
    favors first-in-class over non-first-in-class
    development in many ways, such as through faster
    approval or greater revenue, this finding has
    strategic implications for a wide array of market
    participants, both large and small.

Alignment of First-in-Class Molecular Target
with Disease Processes and Genetics
  • PD is a complex and multifaceted disease with a
    complex interplay between different pathological
    processes. Enormous research efforts and
    significant technological advances have furthered
    knowledge of the neuroanatomy of the basal
    ganglia and of the fundamental processes
    underlying neurodegeneration, helped by the
    ongoing identification of susceptibility genes
    and causative genes in familial PD. Although the
    exact mechanisms that initiate onset remain
    unclear, these insights have been translated into
    the pool of novel therapeutic targets, which may
    potentially become disease-modifying therapies by
    aligning to the disease processes and some
    genetic determinants of PD.
  • GBI Researchs proprietary analysis showed
    substantial variation in how well the functional
    roles of PD first-in-class targets align to the
    pathophysiology of PD. Further in-depth analysis
    identified the most promising first-in-class
    targets based on various scientific and clinical
    parameters. Examining scientific and clinical
    data of promising first-in-class targets showed
    that first-in-class status is not, in its own
    right, enough for a successful product however,
    the first-in-class products substantiated by
    scientific and clinical evidence will be exciting
    future prospects with the potential to transform
    the global parkinson's disease market.

  • The report analyzes innovation in PD in the
    context of the overall pipeline and current
    market landscape. It also analyzes the deals
    landscape surrounding first-in-class products and
    pinpoints in-licensing opportunities. The report
    includes -
  • - A brief introduction to PD, including symptoms,
    pathophysiology, and an overview of
    pharmacotherapy and treatment algorithms
  • - Coverage of the changing molecular target
    landscape and particular points of innovation in
    the pipeline
  • - A comprehensive review of the pipeline for
    first-in-class therapies, analyzed by stage of
    development, molecule type and molecular target
  • - Identification and assessment of first-in-class
    molecular targets with a particular focus on
    early-stage programs of which clinical utility
    has yet to be evaluated, as well as literature
    reviews of novel molecular targets
  • Industry-wide analysis of first-in-class deals
    compared to non-first-in-class deals
  •  Check Full Report on
  • http//

Reasons to buy
  • The report will enable business development and
    enable marketing executives to strategize their
    product launches by allowing them to -
  • - Understand the focal shifts in molecular
    targets in the PD pipeline
  • - Understand the distribution of pipeline
    programs by phase of development, molecule type
    and molecular target
  • - Access a scientific and clinical analysis of
    first-in-class developmental programs for PD,
    benchmarked against non-first-in-class targets
  • - Assess the valuations of licensed and
    co-developed PD treatments

Table of Contents
Global Parkinson's Disease Market Research -
Frontier Pharma
List of Tables
Executive Summary
Clinical and Commercial Landscape
The Case for Innovation
Price Chart
  • Report Name Global Parkinson's Disease Market
    Research - Frontier Pharma
  • Product Price

License Type Price
PDF 6295.5
Site License 11891.5
Enterprise Wide License 20985
Click Here
To View OR Purchase Report
Related Market Research Report
  • Oxidative Stress Assay Market by Product
    (Consumables, Instruments, Services), Test Type
    (Indirect, Enzyme-based, Reactive Oxygen Species
    (ROS)-based), Technology (ELISA, Chromatography,
    Flow Cytometry), End Users - Global Forecast to
  • European Microscopy Market by Product (Optical
    (Fluorescence, Super-Resolution), Confocal,
    Electron (Transmission), Scanning (AFM)),
    Application (Semiconductor, Life Science,
    Nanotechnology), End User (Academic Institute,
    Industries) - Forecast to 2020
  • Immunoassay Market by Technology (ELISA,
    Fluorescence, Colorimetric, Chemiluminescence,
    Rapid Test, Western Blot, ELISPOT, PCR),
    Application (Infectious Disease, Endocrinology,
    Cardiology, Oncology, Hematology), End User -
    Global Forecast to 2019
  • Genotyping Market by Technology (Polymerase Chain
    Reaction, Sequencing, Microarray,
    Electrophoresis, MALDI_TOF), Application
    (Pharmacogenomics, Diagnostic Research, Animal
    Genetics, Agricultural Biotechnology) by
    Products - Global Forecast to 2020
  • Bioburden Testing Market by Product Instrument
    (PCR, Microscopes), Consumables (Kit,
    Reagent), Test (Aerobic, Anaerobic, Fungi,
    Spore), Application (Raw Material, In-process)
    End User (Pharmaceutical, Biotechnology, CMO) -
    Forecast to 2019
  • EMR/EHR Market in the US 2015-2019
  • Global Capsule Endoscopes Market 2015-2019
  • Global Diabetic Retinopathy Market 2015-2019
  • Electrophoresis Market by Product (1D 2D Gel
    Electrophoresis, Agarose Polyacrylamide Gel,
    Capillary Electrophoresis, Isoelectric Focusing,
    Isotachophoresis, CZE, CGE, MEKC, Reagents,
    Informatics), Application End User - Global
    Forecast to 2020
  • Healthcare and Medical Market Research

About JSB Market Research
  • JSB market research is amongst the best online
    market research companies providing the most
    significant online database of various industry
    research reports and services. This online portal
    contains high-quality market research reports
    with well-researched content on a wide range of
    industries. We specialize in providing the best
    market research reports for various industries.
  • Also JSBs database consists of detailed
    insights of the leading players in the global
    market, products and trends also find latest
    updates on global conference events.

Contact Us
  • Support General Inquiries
  • Mail
    91 - 998 729 5242
  • Billing Support
  • Mail
  • Website http//
Write a Comment
User Comments (0)